Cesca Therapeutics (KOOL) Cool Session; Hawaiian Holdings (HA) Soars on Results


The price of Cesca Therapeutics Inc. (Nasdaq:KOOL) stock skyrocketed more than 50% – surpassing the $0.22 mark – in early trade Wednesday. However, there appears to be no relevant information in the street that may explain the stock’s move

KOOL shares are trading at around $0.1931, up $0.054 (or +38.82%), and 422,077 of its shares exchanged hands so far, a large increase in activity versus its average volume (3m) of 220,676

Cesca Therapeutics, an autologous cell-based regenerative medicine company, has 42.81M Shares Outstanding and KOOL stock one-year range is from $0.08 to $1.09 per share



Shares of Hawaiian Holdings Inc. (Nasdaq:HA) soared on Wednesday’s trading session after the company delivered above-consensus quarterly profit and revenue numbers in its financial results

For the fourth quarter 2015, the parent company of Hawaiian Airlines posted revenues of $574.15 million and adjusted net income of $48.5 million or $0.85 per diluted share, topping the Capital IQ Consensus Estimate of $0.84 earnings per share on revenues of $567.18 million for the period

Brokerage firm Deutsche Bank upgraded the company’s stock from a Hold to a to Buy rating and raised its price target from $35.00 to $40.00. Investment analysts at Sterne Agee CRT also boosted their price objective on shares of Hawaiian Holdings from $50.00 to $58.00

HA stock is exchanging hands for about $37.11, up $4.76 (or +14.71%), with 3,643,444 sahres traded so far

Hawaiian Holdings, which engages in the scheduled air transportation of passengers and cargo, has 53.21M Shares Outstanding and HA stock 52-week range is between $18.01 and $40.13 per share


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://galaxystocks.com/disclaimer/